Updated for 2026
AGPCNP pharmacology: safe prescribing in older adults and age-related drug considerations
Age-related pharmacokinetic and pharmacodynamic changes make prescribing in older adults fundamentally different from prescribing in younger adults. AGPCNP certification tests knowledge of how aging affects drug absorption, distribution, metabolism, and elimination — and how these changes modify dosing, monitoring, and adverse effect risk.
Educational purpose: This content is for exam preparation and professional development only. It is not intended for clinical decision-making. Always follow current guidelines, institutional policies, and scope of practice.
Age-related pharmacokinetic changes
Absorption: Decreased gastric acid (atrophic gastritis common) → affects pH-dependent drugs; slowed GI motility → delayed peak drug levels. Generally modest clinical impact.
Distribution: Decreased lean body mass + increased body fat → fat-soluble drugs (lipophilic: benzodiazepines, warfarin, lipid-soluble opioids) have increased Vd and prolonged half-life. Decreased total body water → water-soluble drugs (digoxin, lithium, ethanol) reach higher concentrations at same dose. Decreased serum albumin in frail/malnourished → more free drug for highly protein-bound medications (phenytoin, warfarin).
Metabolism: Decreased hepatic blood flow and hepatic mass → reduced first-pass and clearance of high-extraction-ratio drugs (morphine, lidocaine, propranolol, nitrates). Phase I (CYP450) metabolism decreases; Phase II (conjugation — glucuronidation, sulfation) better preserved. Lorazepam, oxazepam, temazepam (LOT) are preferred benzodiazepines in elderly (Phase II only — no active metabolites).
Elimination: Renal clearance decreases ~1% per year after age 40 due to declining GFR. Serum creatinine may be normal despite significant GFR decline (decreased muscle mass = less creatinine production). Use CG (Cockcroft-Gault) or CKD-EPI with lean body weight for renal dosing in elderly. Renally cleared drugs requiring dose reduction: digoxin, metformin, NSAIDs, gabapentin, most antibiotics.
Pain management in older adults — WHO ladder and opioid safety
WHO analgesic ladder for older adults:
- Step 1: Non-opioid — acetaminophen is first-line for mild-moderate pain in elderly (effective, renal-safe; avoid NSAIDs). Maximum dose: 2–3 g/day in frail elderly (hepatic metabolism decreased; 4 g/day max for healthy adults)
- Step 2: Mild opioids or low-dose strong opioids — tramadol: AVOID in elderly (serotonin syndrome risk, seizure risk, anticholinergic effects, lowers seizure threshold)
- Step 3: Strong opioids — start low, go slow. Preferred in elderly: morphine, oxycodone, hydromorphone (active metabolites accumulate in renal failure — reduce/avoid). Fentanyl patch for stable pain (not acute).
Opioid safety in older adults: Constipation — prescribe bowel regimen prophylactically with every opioid prescription (stimulant laxative: sennosides). Fall risk — reassess at every visit. Respiratory depression — lower dose threshold than younger adults. Cognitive effects — delirium risk. Anticipate increased sensitivity to CNS effects.
Gabapentinoids: Gabapentin and pregabalin: effective for neuropathic pain and adjuncts for chronic pain; however, increase fall risk and CNS sedation in elderly. Renally cleared — dose-adjust for eGFR. Start at 100–300 mg/day in elderly (not 900 mg like younger adults).
Frequently asked questions
- Why is serum creatinine unreliable for assessing renal function in older adults?
- Serum creatinine is a product of muscle metabolism — lean muscle mass generates creatinine, and older adults have substantially reduced muscle mass (sarcopenia). A 75-year-old with a serum creatinine of 0.8 mg/dL (within normal range) may have an eGFR of only 40–50 mL/min due to their low muscle mass generating less creatinine relative to their actual nephron function. Using serum creatinine alone or calculating eGFR with actual weight in a malnourished elderly patient will systematically overestimate renal function. For drug dosing in older adults: use the Cockcroft-Gault equation with lean body weight to estimate creatinine clearance (CrCl), not eGFR from CKD-EPI. If CrCl appears surprisingly high (>120) in a frail small elderly patient — use a maximum of 120 mL/min cap or consider capping at actual measured values.
Clinically reviewed by NurseNest Clinical Review Team · Last updated 2026-06-10 · For educational purposes only · Review policy